This announcement is a separate document:
浙江天册律师事务所关于浙江圣达生物药业股份有限公司2024年员工持股计划的法律意见书
Zhejiang TianCe Law Firm's Legal Opinion on Zhejiang Shengda Bio-Pharmaceutical Co., Ltd.'s Employee Stock Ownership Plan for 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.